PublizoomBRISTOL-MYERS SQUIBB, S.A.U.
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 6
- Amount won alone
- €2,539,930 excl. VAT
- Shared contracts
- 4 (multi-supplier framework agreements)
- Period
- 2 September 2026 – 9 October 2026
Its main clients
- Área Sanitaria da Coruña e Cee - Servicio Gallego de Salud · 1 contract
- Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza · 1 contract
- Servicio Gallego de Salud - Área Sanitaria de Lugo, A Mariña y Monforte de Lemos · 1 contract
- Servicio Cántabro de Salud · 1 contract
- Consorci Sanitari de l'Anoia · 1 contract
- Consorci Hospital Clínic de Barcelona (HCB) · 1 contract
Where and what
Supplies · 6
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 28 July 2027 re-tender around January 2027 |
2026-90 Suministro del medicamento Lisocabtágeno maraleucel (Breyanzi®) para el Hospital Clínic de Barcelona (HCB).
Consorci Hospital Clínic de Barcelona (HCB) framework agreement |
BRISTOL-MYERS SQUIBB, S.A.U. 1 bid received |
€2,539,930 |
| 10 September 2028 re-tender around March 2028 |
Suministro sucesivo del medicamento "Lisocabtagen Maraleucel"
Área Sanitaria da Coruña e Cee - Servicio Gallego de Salud framework agreement |
BRISTOL-MYERS SQUIBB, S.A.U. 1 bid received |
– |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.